EUA
CorDx TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test
FDA Emergency Use Authorization · CorDx, Inc. · Jan 14, 2025
Key facts
| Product | CorDx TyFast Flu A/B & COVID-19 At Home Multiplex Rapid Test |
|---|---|
| Company | CorDx, Inc. |
| Product type | Lateral Flow, Visual Read, Over the Counter (OTC) Home Testing, Multi-analyte, Single Target |
| Date | Jan 14, 2025 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 10–99 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: